SC
AGN

SRB Corp’s Allergan plc AGN Stock Holding History

SRB Corp’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-797
Closed -$163K – 193
2017
Q3 		$163K Sell
797
-26
-3% -$6.05K 0.02% 170
2017
Q2 		$200K Buy
823
+97
+13% +$22.8K 0.03% 25
2017
Q1 		$173K Sell
726
-168
-19% -$39.1K 0.02% 127
2016
Q4 		$188K Buy
+894
New +$185K 0.03% 26
2016
Q3 		– Sell
-596
Closed -$138K – 193
2016
Q2 		$138K Buy
+596
New +$137K 0.02% 129

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

SRB Corp's AGN Position: Q4 2017 in Review

SRB Corp sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 797 shares — an estimated $163K sold.

SRB Corp first reported a position in AGN in Q2 2016 and held it in 5 quarters. The position peaked at $200K in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • SRB Corp reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • SRB Corp sold 797 Allergan plc shares in Q4 2017, an estimated $163K.
  • SRB Corp first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • SRB Corp's Allergan plc position peaked at $200K in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on SRB Corp's 13F filing for Q4 2017, filed 14 Feb 2018.